Cargando…

Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis

Symptomatic treatment of Multiple Sclerosis (MS) is crucial, since it helps to lessen the limitations that affect patients’ daily lives. Tremors are a significant and frequent symptom in MS patients. However, there is still a lack of evidence supporting a specific therapeutic approach for MS patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldarwish, Walaa A., Ali, Eman N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Riyadh : Armed Forces Hospital 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155481/
https://www.ncbi.nlm.nih.gov/pubmed/37045459
http://dx.doi.org/10.17712/nsj.2023.2.20220102
_version_ 1785036338062426112
author Aldarwish, Walaa A.
Ali, Eman N.
author_facet Aldarwish, Walaa A.
Ali, Eman N.
author_sort Aldarwish, Walaa A.
collection PubMed
description Symptomatic treatment of Multiple Sclerosis (MS) is crucial, since it helps to lessen the limitations that affect patients’ daily lives. Tremors are a significant and frequent symptom in MS patients. However, there is still a lack of evidence supporting a specific therapeutic approach for MS patients’ tremors. A 41-year-old man with a history of MS is presented in this study. He exhibited stiffness and tremors at the follow-up clinic, which affected his daily activities. For his spasticity, he received intrathecal baclofen (ITB). The patient’s symptoms responded well to this treatment, as both stiffness and tremors decreased. In an MS patient, ITB therapy thus unexpectedly reduced and improved tremor symptoms.
format Online
Article
Text
id pubmed-10155481
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Riyadh : Armed Forces Hospital
record_format MEDLINE/PubMed
spelling pubmed-101554812023-05-04 Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis Aldarwish, Walaa A. Ali, Eman N. Neurosciences (Riyadh) Case Report Symptomatic treatment of Multiple Sclerosis (MS) is crucial, since it helps to lessen the limitations that affect patients’ daily lives. Tremors are a significant and frequent symptom in MS patients. However, there is still a lack of evidence supporting a specific therapeutic approach for MS patients’ tremors. A 41-year-old man with a history of MS is presented in this study. He exhibited stiffness and tremors at the follow-up clinic, which affected his daily activities. For his spasticity, he received intrathecal baclofen (ITB). The patient’s symptoms responded well to this treatment, as both stiffness and tremors decreased. In an MS patient, ITB therapy thus unexpectedly reduced and improved tremor symptoms. Riyadh : Armed Forces Hospital 2023-04 /pmc/articles/PMC10155481/ /pubmed/37045459 http://dx.doi.org/10.17712/nsj.2023.2.20220102 Text en Copyright: © Neurosciences https://creativecommons.org/licenses/by-nc/3.0/Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.
spellingShingle Case Report
Aldarwish, Walaa A.
Ali, Eman N.
Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis
title Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis
title_full Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis
title_fullStr Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis
title_full_unstemmed Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis
title_short Effects of intrathecal Baclofen in reducing tremors in patients with multiple sclerosis
title_sort effects of intrathecal baclofen in reducing tremors in patients with multiple sclerosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155481/
https://www.ncbi.nlm.nih.gov/pubmed/37045459
http://dx.doi.org/10.17712/nsj.2023.2.20220102
work_keys_str_mv AT aldarwishwalaaa effectsofintrathecalbaclofeninreducingtremorsinpatientswithmultiplesclerosis
AT aliemann effectsofintrathecalbaclofeninreducingtremorsinpatientswithmultiplesclerosis